4
Clinical Trials associated with Anakinra biosimilar(Hamad Medical Corp.) / Not yet recruitingPhase 3IIT An open prospective randomized therapeutic trial using ANAKINRA or TOCILIZUMAB alone or in combination with RUXOLITINIB in severe stage 2b and 3 COVID-19 disease - INFLAMMACOV
/ Not yet recruitingPhase 2IIT Anakinra: Efficacy of interleukin-1 pathway inhibitor anakinra for the management of fever during neutropenia and mucositis in patients with multiple myeloma receiving an autologous hematopoietic stem cell transplantation after high-dose melphalan – A randomized controlled trial - AFFECT-2
/ Unknown statusPhase 4IIT Treatment with Recombinant human Interleukin 1 receptor antagonist (Anakinra) in patients with Anaplastic Thyroid Cancer: a proof of concept study - ATC-Anakinra1
100 Clinical Results associated with Anakinra biosimilar(Hamad Medical Corp.)
100 Translational Medicine associated with Anakinra biosimilar(Hamad Medical Corp.)
100 Patents (Medical) associated with Anakinra biosimilar(Hamad Medical Corp.)
100 Deals associated with Anakinra biosimilar(Hamad Medical Corp.)